OCUGEN, INC. Other Non-Current Liabilities
OCUGEN, INC. (OCGN) had Other Non-Current Liabilities of $2.91 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Noncurrent $2.91M.
- 2026-03-31: Other Liabilities, Noncurrent $2.95M.
- 2025-12-31: Other Liabilities, Noncurrent $1.60M.
- 2025-09-30: Other Liabilities, Noncurrent $1.59M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $2.91M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.95M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $1.60M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.59M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $583.00K 10-Q · filed 2025-08-04 |
| 2025-03-31 | $573.00K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $564.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $554.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $545.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $536.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $527.00K 10-K · filed 2025-03-05 |
| 2023-09-30 | $497.00K 10-K · filed 2024-04-16 |
| 2023-06-30 | $455.00K 10-K · filed 2024-04-16 |
| 2023-03-31 | $309.00K 10-K · filed 2024-04-16 |
| 2022-12-31 | $244.00K 10-K · filed 2024-04-16 |
| 2022-09-30 | $0.00 10-K · filed 2024-04-16 |
| 2022-06-30 | $0.00 10-K · filed 2024-04-16 |
| 2022-03-31 | $0.00 10-K · filed 2024-04-16 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-19 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-14 |
| 2020-03-31 | $3.94K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $9.76K 10-K · filed 2021-03-19 |
| 2018-12-31 | $37.46K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |